𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The proteasome as a potential target for novel anticancer drugs and chemosensitizers

✍ Scribed by Kristin R. Landis-Piwowar; Vesna Milacic; Di Chen; Huanjie Yang; Yunfeng Zhao; Tak Hang Chan; Bing Yan; Q. Ping Dou

Book ID
116413255
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
613 KB
Volume
9
Category
Article
ISSN
1368-7646

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The ubiquitin-proteasome system: A novel
The ubiquitin-proteasome system: A novel target for anticancer and anti-inflammatory drug research
✍ Halina Ostrowska πŸ“‚ Article πŸ“… 2008 πŸ› SP Versita 🌐 English βš– 419 KB

## Abstract The ubiquitin-proteasome system is responsible for the degradation of most intracellular proteins, including those that control cell cycle progression, apoptosis, signal transduction and the NF-ΞΊB transcriptional pathway. Aberrations in the ubiquitin-proteasome system underlie the patho

ROS receptor tyrosine kinase: a new pote
ROS receptor tyrosine kinase: a new potential target for anticancer drugs
✍ Ibrahim Mustafa El-Deeb; Kyung Ho Yoo; So Ha Lee πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 233 KB

ROS kinase is one of the last two remaining orphan receptor tyrosine kinases with an as yet unidentified ligand. The normal functions of human ROS kinase in different body tissues have not been fully identified so far. However, the ectopic expression, as well as the production of variable mutant for